JP2018500322A5 - - Google Patents

Download PDF

Info

Publication number
JP2018500322A5
JP2018500322A5 JP2017532039A JP2017532039A JP2018500322A5 JP 2018500322 A5 JP2018500322 A5 JP 2018500322A5 JP 2017532039 A JP2017532039 A JP 2017532039A JP 2017532039 A JP2017532039 A JP 2017532039A JP 2018500322 A5 JP2018500322 A5 JP 2018500322A5
Authority
JP
Japan
Prior art keywords
immunogenic composition
composition according
years
vzv
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017532039A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018500322A (ja
Filing date
Publication date
Priority claimed from GB201503266A external-priority patent/GB201503266D0/en
Priority claimed from GBGB1518917.8A external-priority patent/GB201518917D0/en
Application filed filed Critical
Priority claimed from PCT/EP2015/079967 external-priority patent/WO2016096968A1/en
Publication of JP2018500322A publication Critical patent/JP2018500322A/ja
Publication of JP2018500322A5 publication Critical patent/JP2018500322A5/ja
Pending legal-status Critical Current

Links

JP2017532039A 2014-12-18 2015-12-16 ワクチン接種 Pending JP2018500322A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB1422686.4 2014-12-18
GB201422686 2014-12-18
GB201503266A GB201503266D0 (en) 2015-02-26 2015-02-26 Vaccination
GB1503266.7 2015-02-26
GBGB1518917.8A GB201518917D0 (en) 2015-10-26 2015-10-26 Vaccination
GB1518917.8 2015-10-26
PCT/EP2015/079967 WO2016096968A1 (en) 2014-12-18 2015-12-16 Vaccination

Publications (2)

Publication Number Publication Date
JP2018500322A JP2018500322A (ja) 2018-01-11
JP2018500322A5 true JP2018500322A5 (enExample) 2018-12-27

Family

ID=54937057

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017532039A Pending JP2018500322A (ja) 2014-12-18 2015-12-16 ワクチン接種

Country Status (8)

Country Link
US (1) US20180008700A1 (enExample)
EP (1) EP3233118A1 (enExample)
JP (1) JP2018500322A (enExample)
CN (1) CN107106675A (enExample)
BR (1) BR112017012647A2 (enExample)
CA (1) CA2970840A1 (enExample)
MX (1) MX2017008055A (enExample)
WO (1) WO2016096968A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6925688B2 (ja) * 2015-10-22 2021-08-25 モデルナティーエックス， インコーポレイテッド 水痘帯状疱疹ウイルス（ｖｚｖ）のための核酸ワクチン
SG10202012205XA (en) 2015-11-06 2021-01-28 Adjuvance Technologies Inc Triterpene saponin analogues
IL292991A (en) 2017-04-25 2022-07-01 Adjuvance Tech Inc Triterpene saponin analogs
US20210187098A1 (en) * 2017-04-28 2021-06-24 Glaxosmithkline Biologicals Sa Vaccination
MY195490A (en) * 2018-05-23 2023-01-26 Mogam Inst Biomedical Res Antigen Variant Of Varicella Zoster Virus And Use Thereof
CN109602901B (zh) * 2019-01-08 2022-05-27 成都迈科康生物科技有限公司 一种带状疱疹病毒疫苗及其制备方法和应用
US12070495B2 (en) 2019-03-15 2024-08-27 Modernatx, Inc. HIV RNA vaccines
CN114630671A (zh) * 2019-11-05 2022-06-14 佐剂技术公司 水痘带状疱疹
CN115768892A (zh) 2020-03-09 2023-03-07 戴纳瓦克斯技术公司 包含tlr9激动剂的带状疱疹疫苗
WO2023223255A1 (en) * 2022-05-20 2023-11-23 Glaxosmithkline Biologicals Sa Modified varicella zoster virus glycoprotein e proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0504436D0 (en) * 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine
TWI457133B (zh) * 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物

Similar Documents

Publication Publication Date Title
JP2018500322A5 (enExample)
US20230116042A1 (en) Adjuvant formulations comprising tlr4 agonists and methods of using the same
EP2664332B1 (en) Vaccine composition containing synthetic adjuvant
Kamphuis et al. Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats
CN1391483A (zh) 作为佐剂的聚氧乙烯脱水山梨醇酯和辛苯昔醇组合及其在疫苗中的应用
US11951161B2 (en) Methods for inducing an immune response
JP2003523310A (ja) 新規インフルエンザウイルスワクチン組成物
HUP0203817A2 (hu) Polioxietilén-alkil-étert vagy -észtert és legalább egy nemionos felületaktív anyagot tartalmazó adjuváns
BRPI0716959A2 (pt) Composição de vacina contendo adjuvante sintético
JP2018500322A (ja) ワクチン接種
JP2017511327A5 (enExample)
CN110621339A (zh) 疫苗接种
CA3157372A1 (en) Varicella zoster
Silveira et al. Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice
EP2621524A1 (en) Improved vaccine compositions
EP3119428B1 (en) Toll-like receptor 2 agonists and vaccines and uses thereof
AR103030A1 (es) Composición inmunógena
Lee EFFECTS OF VACCINE PLATFORMS AND ADJUVANTS ON PROTECTIVE EFFICACY AGAINST HUMAN RESPIRATORY SYNCYTIAL VIRUS
HK1191545B (en) Vaccine composition containing synthetic adjuvant